Research Focus

Former Employee. Graduate Staff; Medical Student

Recent additions – View all

1. Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia

   Journal Article

   Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
   Leukemia Research (2022)

   Fulltext@MSK | Save
2. Dermatologic adverse events in acute myeloid leukemia patients treated with IDH inhibitors ivosidenib and enasidenib

   Meeting Abstract

   Parisi, R.; Stoll, J.; Zhu, H.
   Journal of the American Academy of Dermatology (2022)

   Fulltext@MSK | Save